2020年10月29日星期四

Election Day Could Be Rocket Fuel for Cannabis Stocks

Legacy Research Group

October 29, 2020

Chris Lowe
Chris Lowe

Get ready for a "green wave" on Election Day... Trump – the most cannabis-friendly president in history... In the mailbag: Is bitcoin "vastly superior" to gold?...


If you’re like most folks, you’re sick of hearing about the election...

This year, the partisan attacks have been sharper than ever before in living memory.

Both sides say the other is a danger to democracy. Social media has become a cesspool of tribal bickering. And just about every second of coverage in the mainstream press is of the mudslinging contest between Donald Trump and Joe Biden.

But here at the Cut, we don’t do mainstream. Our mission is to help spot market megatrends early on... so you can profit ahead of the crowd.

And our analysts have been tracking a different kind of vote taking place on November 3.

I (Chris Lowe) am talking about the proposed cannabis legalization initiatives on the ballots in Arizona, Mississippi, Montana, New Jersey, and South Dakota.

As you’ll see today, they could grow the legal cannabis market in the U.S. by 20% – overnight.

So if you already own cannabis stocks, hang on to your hat. This will act as rocket fuel for share prices of the best cannabis companies.

And if you haven’t yet picked up exposure to the legal cannabis megatrend... now is a great time to buy.

There’s strong support for the legalization initiatives...

It’s all in this chart of the latest state polls...

Chart

As you can see, New Jersey voters are expected to approve adult-use (medical and recreational) legalization in a landslide.

About 55% of Arizona voters favor an adult-use legalization bill in their state. And in Montana, there’s a 10-point lead in favor of adult-use legalization.

In South Dakota, a medical legalization bill looks set to pass, while an adult-use legalization bill is neck and neck. And in Mississippi, there’s a roughly 50-50 chance of a medical cannabis initiative passing.

It’s something colleague Teeka Tiwari has been tracking closely at our Palm Beach Venture advisory.

As regular readers know, that’s where Teeka and his right-hand man, William Mikula, recommend shares in companies before they go public and list on an exchange.

And one of their first recommendations was an early-stage cannabis company.

Imminent FDA Approval Could Send This Tiny Biotech Soaring

Here’s Teeka with more on why the election will be good news for the legal cannabis industry...

We’ve been following this space for more than a year now. We know that, once a state legalizes cannabis, it puts pressure on neighboring states to do the same. Otherwise, they miss out on the tax revenue.

South Dakota and Montana would open up the Midwest market. Arizona would continue growing the momentum in the Southwest that Nevada and California started. New Jersey could be the domino to tip even bigger New York over the edge.

The reason these initiatives matter for investors is simple. Teeka again...

As the underlying market for legal cannabis expands, the revenue and profit opportunities for the best companies in the space expand as well.

One of these dominoes falling would be big. If a few fall, it’ll be massive. The addressable U.S. market would grow by about 20% overnight. As each new state falls in line, hundreds of millions in sales opportunities open up.

There’s another reason cannabis stocks are a great bet right now – the COVID-19 pandemic.

Cannabis sales have surged during the pandemic...

As we spotlighted in these pages in April, lawmakers in 28 states where the plant is legal have deemed cannabis businesses “essential”... just like grocery stores.

And sales are booming.

States across the U.S. are seeing monthly sales figures few thought possible.

Take Utah... It launched its medical cannabis program in March. As of the end of August, sales totaled $8 million. Monthly sales now exceed $2 million. This puts the program on pace to generate $25 million in sales on an annual basis.

That may not be eye-popping if you’re familiar with some of the larger states’ sales figures. California, for instance, sold $348 million of cannabis in July alone.

But when you compare that $25 million to the $4 million Utah’s cannabis sales were projected to earn in their first year... it’s clear demand is blowing expectations out of the water.

States such as Illinois, Oregon, Colorado, and Washington have all reported record-high monthly sales over the past few months.

These booming sales should come as no surprise. Cannabis helps folks cope with anxiety and depression. It’s also a stress reliever.

And with a virus on the loose... and the widespread panic it’s unleashed...

There’s plenty to be stressed about in 2020. So rising cannabis sales are natural.

Something similar happened with alcohol sales during the 2007-09 crisis and recession. Take a look...

Chart

As the recession hit... folks bought more booze.

Cannabis stocks are in a sweet spot right now...

This next chart is of the Horizons Marijuana Life Sciences Index ETF (HMLSF). This exchange-traded fund is made up of the 29 largest cannabis stocks. It’s widely considered a stand-in for the legal cannabis sector.

As you can see, it’s down 75% from its peak in March 2019.

Chart

But here’s what’s so interesting... cannabis sales are booming.

And that’s a sweet spot for contrarian investors. These stocks are so out of favor with investors, they’re selling at bargain-basement prices.

As Teeka explained in these pages in May...

Last year, a boatload of negative headlines hit the legal cannabis sector. Mainstream investors panicked and sold their stocks… which crushed prices.

But as usual, the mainstream ignored what was going on under the hood. The fundamentals – sales, market share, and profits – are telling a completely different story.

When investor sentiment finally catches up to booming sales, we’ll see a new cycle that’ll take this sector to new highs. Companies trading near their bottoms could soar 5, 10, or even 100 times or more when investor sentiment flips.

Even better, cannabis stocks are set to do well... no matter who’s president next.

Take President Trump...

He hasn’t said much about cannabis legalization. But when asked, he’s staunchly defended states’ rights to make up their own minds.

And although he made Washington War on Drugs warrior Jeff Sessions his Attorney General... he never backed Sessions’ crusade against cannabis.

Trump signed into law the 2018 Farm Bill. It legalized hemp, a close cousin of cannabis with extremely low levels of THC, one of the main psychoactive ingredients in cannabis.

It might sound bombastic... but Trump may go down as one of the biggest friends of cannabis of all the presidents in history.

His administration is the only one in modern times that didn’t carry out any large-scale raids on legal cannabis businesses.

If Trump wins next week, there’s no reason to expect any change. He’ll continue to stay out of the way of cannabis companies. And he’ll continue to let the states decide.

But what if he loses?

Joe Biden started out as a War on Drugs warrior...

In the 1980s and 1990s, Biden was one of the main proponents of the crime bills that led to locking up millions of people for minor drug offenses.

But he’s shifted with the times.

Today, Biden supports cannabis decriminalization. He’s stopped short of endorsing legalization.

But that hardly matters. The Democratic Party behind Biden is pro-cannabis. If he wins, it’s likely Democrats will also win big in Congress.

And if that happens, it’s only a matter of time before they begin to pass bills making it easier for cannabis companies to operate, and ultimately making cannabis federally legal.

How to play it?

One way to get exposure to the coming upside in cannabis stocks is to buy shares in HMLSF.

It tracks the 29 leading cannabis stocks and will give you broad exposure to the cannabis industry.

But keep your position size small. As Teeka has been showing his readers, the beauty of investing in a young industry like this is you don’t have to risk much to make outsized profits.

In the mailbag: Is bitcoin “vastly superior” to gold?...

At the Cut, we’re bullish on bitcoin...

We’ve been urging you to add some to your portfolio since we created this premium e-letter for all paid-up Legacy Research subscribers in 2018.

Governments and their central banks can’t inflate away bitcoin’s value. That means bitcoin will be a better store of wealth over the next decade and beyond.

In fact, as Teeka showed on Tuesday, bitcoin could hit $60,000 a lot sooner than most folks think... as innovation and adoption ramp up.

Colleagues Jeff Brown (The Near Future Report) and Nick Giambruno (The Casey Report) are also bullish on bitcoin.

But our globetrotting gold bug, Tom Dyson, says bitcoin is fatally flawed. That’s because – unlike gold, which is used in jewelry and tech – it has no intrinsic worth.

As Tom put it, bitcoin is just a “clump of electrons.” And it’s definitely gotten his readers thinking...

I figured I’d share my 2 satoshis on this [a satoshi is the smallest unit of bitcoin, like a cent is the smallest unit of the dollar]...

Money is an idea. It’s a language that communicates value. The medium is irrelevant – so long as it has the key characteristics of sound money.

The financial industry is going through the same transition that the music and film industries went through in the 2000s. The value of music is in the ability to listen to it on demand. It’s not in the record, CD, tape, or whatever it’s stored on.

It’s the same with money. Bitcoin is a vastly superior method of transmitting and managing value.

– Jeremy M.

If bitcoin is such a bad idea, why are so many central banks seriously thinking of adopting CBDCs [central bank digital currencies]?

These government currencies can be printed ad nauseam. Bitcoin is capped at 21 million. Time will tell, but I am on the side of bitcoin.

– John K.

I love the investment. It does not need intrinsic value immediately. That will come through adoption – which is coming.

– Randy W.

I’m concerned no one ever mentions the current IRS regulations that ALL crypto “transactions” are reportable as a “capital asset buy/sell.” That means keeping track of every transaction, and assigning a cost to the bitcoin sold.

Reporting would be a nightmare if you often use bitcoin to pay for things, or buy and sell different amounts of bitcoin at different times.

– Joseph H.

By ignoring bitcoin as an immediate opportunity, Tom will be missing a nice boost in capital that could be used to leverage his gold play. The caveat is bitcoin should probably not be a long-term investment. When trading it becomes easy to do via any brokerage account, it will be time to get out.

– Roger H.

Is Tom missing an opportunity in bitcoin? Or is he right to dismiss bitcoin as a “clump of electrons”?

Have your say at feedback@legacyresearch.com.

Regards,

signature

Chris Lowe
October 29, 2020
Bray, Ireland

Like what you’re reading? Send your thoughts to feedback@legacyresearch.com.

IN CASE YOU MISSED IT…

Biden Leads in Battleground States – Are You Ready?

Business Insider reports: "Joe Biden wants to bring America back to Obama's policies." And according to a recent CNBC poll, Biden beats Trump nationally… and in 6 battleground states.

Joe even admitted he plans to raise taxes and said "a lot of you may not like that…"

If he wins, it could have huge implications for your savings and retirement.

But no matter what happens in November…

Teeka Tiwari – a New York dock worker turned Wall Street millionaire – reveals three ultra-critical steps you can take to prepare.

Watch His Urgent Video Now.

image


Get Instant Access

Click to read these free reports and automatically sign up for daily research.

image

Trading Basics: Two Building Blocks Every Trader MUST Know

image

Free Report: America's #1 Portfolio Protection Plan

image

How You Can Start Profiting From Maganomics Today

Share FACEBOOK
Tweet TWITTER

To ensure our emails continue reaching your inbox, please add our email address to your address book.

This editorial email containing advertisements was sent to its028@gmail.com because you subscribed to this service. To stop receiving these emails, click here.

Legacy Research Group welcomes your feedback and questions. But please note: The law prohibits us from giving personalized advice.

To contact Customer Service, call toll free Domestic/International: 1-888-413-5232, Mon–Fri, 9am–5pm ET, or email us here. 55 NE 5th Avenue, Delray Beach, FL 33483.

© 2020 Legacy Research Group, LLC. All rights reserved. Any reproduction, copying, or redistribution of our content, in whole or in part, is prohibited without written permission from Legacy Research Group, LLC.

Privacy Policy | Terms of Use

没有评论:

发表评论